Sector
PharmaceuticalsOpen
₹6.4Prev. Close
₹6.7Turnover(Lac.)
₹22.62Day's High
₹6.4Day's Low
₹6.452 Week's High
₹052 Week's Low
₹0Book Value
₹54.77Face Value
₹10Mkt Cap (₹ Cr.)
70.13P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Equity Capital | 31.66 | 13.89 | 13.89 | 7.58 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 376.21 | 295.58 | 335.91 | 126.81 |
Net Worth | 407.87 | 309.47 | 349.8 | 134.39 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Revenue | 421.05 | 520.75 | 479.96 | 320.25 |
yoy growth (%) | -19.14 | 8.49 | 49.86 | |
Raw materials | -349.9 | -386.87 | -353.2 | -232.69 |
As % of sales | 83.1 | 74.29 | 73.58 | 72.65 |
Employee costs | -5.62 | -6.72 | -5.64 | -4.62 |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Profit before tax | 1.46 | 47.67 | 63.04 | 54.64 |
Depreciation | -20.44 | -20.22 | -15.66 | -2.58 |
Tax paid | -0.61 | -2.22 | -22.01 | -18.57 |
Working capital | -161.61 | 197.17 | 142.56 | |
Other operating items |
| Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -19.14 | 8.49 | 49.86 | |
Op profit growth | -46.09 | 0.37 | 49.25 | |
EBIT growth | -50.75 | -1.96 | 34.97 | |
Net profit growth | 22.52 | -98.66 | 13.92 |
| Particulars (Rupees in Crores.) | Mar-2014 | Mar-2013 | Mar-2012 |
|---|---|---|---|
Gross Sales | 421.04 | 520.76 | 479.95 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 421.04 | 520.76 | 479.95 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 7.86 | 4.71 | 2.35 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Rajendra Kamat
Director
Anjali Jadhav
Additional Director
Dinesh Surana
K-4/1 Additional MIDC,
Dist Raigad,
Maharashtra - 402309
Tel: -
Website: -
Email: [email protected]
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Summary
Aanjaneya Lifecare Ltd is a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and Fini...
Read More
Reports by Dr.Datsons Labs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.